19568278

Source:http://linkedlifedata.com/resource/pubmed/id/19568278

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0028754, umls-concept:C0036849, umls-concept:C0087111, umls-concept:C0205314, umls-concept:C0679622, umls-concept:C1442518, umls-concept:C1552652, umls-concept:C1552685, umls-concept:C1705195
pubmed:issue	7
pubmed:dateCreated	2009-7-1
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101124171
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1474-1784
pubmed:author	pubmed-author:ChangPeterP
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	529
pubmed:meshHeading	pubmed-meshheading:19568278-Clinical Trials as Topic, pubmed-meshheading:19568278-Drug Therapy, Combination, pubmed-meshheading:19568278-Humans, pubmed-meshheading:19568278-Obesity, pubmed-meshheading:19568278-United States, pubmed-meshheading:19568278-United States Food and Drug Administration
pubmed:year	2009
pubmed:articleTitle	Trial watch: novel obesity therapies set to attract spotlight in Q3 2009.
pubmed:affiliation	Sagient Research Systems, 3655 Nobel Drive Suite 540, San Diego, California 92122, USA. pchang@SagientResearch.com
pubmed:publicationType	Journal Article